Survival from non-stage 4 neuroblastoma without cytotoxic therapy: an analysis of clinical and biological markers
- 1 October 1997
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 33 (12), 2117-2120
- https://doi.org/10.1016/s0959-8049(97)00281-5
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy.Journal of Clinical Oncology, 1996
- Expression of the Gene for Multidrug-Resistance–Associated Protein and Outcome in Patients with NeuroblastomaNew England Journal of Medicine, 1996
- Allelic Loss of Chromosome 1p as a Predictor of Unfavorable Outcome in Patients with NeuroblastomaNew England Journal of Medicine, 1996
- Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.Journal of Clinical Oncology, 1993
- Association between High Levels of Expression of the TRK Gene and Favorable Outcome in Human NeuroblastomaNew England Journal of Medicine, 1993
- Detection of 1p36 deletions in paraffin sections of neuroblastoma tissuesGenes, Chromosomes and Cancer, 1993
- Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1Cancer, 1989
- International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.Journal of Clinical Oncology, 1988
- Association of Multiple Copies of the N-mycOncogene with Rapid Progression of NeuroblastomasNew England Journal of Medicine, 1985
- Cellular DNA Content as a Predictor of Response to Chemotherapy in Infants with Unresectable NeuroblastomaNew England Journal of Medicine, 1984